Search results
Author(s):
Tarun Pandey
,
Kedar Jambhekar
Added:
3 years ago
Diastolic dysfunction and diastolic heart failure (DHF) have shown a steady increase in prevalence over the course of the last decade.1 DHF is now regarded as a major public health concern. It shows an increasing trend with age and exceeds the incidence rate of systolic heart failure by the eighth decade of life.2 In fact, it is estimated that approximately 25–30% of individuals 45 years of age…
View more
Author(s):
Michael H Picard
Added:
3 years ago
Non-invasive imaging of the heart continues to evolve and improve. Cardiovascular ultrasound (echocardiography) continues to play an important role in the diagnosis and assessment of responses to therapy of many cardiac conditions. Even as the clinical applications of newer techniques such as cardiac computed tomography (CT) and cardiac magnetic resonance imaging (CMRI) increase, the role of…
View more
Author(s):
Johannes Sperzel
Added:
6 years ago
Screening: a systematic and efficient way to optimize patient selection at risk for sudden cardiac death - Johannes Sperzel from Bad Nauheim, Germany speaking at HFA 2017.
View more
Author(s):
Maurizio Gasparini
,
Alessio Cappelleri
,
Paola Galimberti
,
et al
Added:
3 years ago
Cardiac resynchronisation therapy (CRT) is an important device-based, non-pharmacological approach that has been shown to improve the outcome in selected patients with chronic heart failure (HF). Large randomised trials have clearly demonstrated that CRT improves left ventricular (LV) function and reduces both morbidity and mortality rates.1–5 Until a few years ago, CRT was indicated in patients…
View more
Author(s):
Elsayed Abd-El-kader Elsayed
Added:
11 months ago
Author(s):
Valentina O Puntmann
,
Anastasia Shchendrygina
,
Carlos Rodriguez Bolanos
,
et al
Added:
5 months ago
Author(s):
Udo Sechtem
Added:
7 years ago
Udo Sechtem discusses "Cardiac imaging in CAD: too much of a good thing?" at the 2016 ESC Congress in Rome, Italy.
View more
Author(s):
Domingo Figal
Added:
10 months ago
ESC-HFA 2023 — Prof Domingo Pascual Figal (Hospital Clinico Universitario Virgen de la Arrixaca, SP) discusses the DAPA MODA study (NCT04707352).
The study aimed to assess the effects of dapagliflozin on cardiac remodeling parameters, particularly LA geometry and function, and biomarkers reflecting pathophysiological pathways. Findings from ESC Heart Failure 2023 revealed that dapagliflozin…
View more
Author(s):
Miriam Reiter
,
Tobias Reichlin
,
Raphael Twerenbold
,
et al
Added:
3 years ago
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. Accordingly, prompt identification of patients with AMI is critical, as established therapies exist that are of proven benefit.1,2 More than 15 million patients per year present to emergency departments with symptoms compatible with acute myocardial ischaemia in the US and Europe; only 20–30%, however, are…
View more
Cavin-2 Deficiency Attenuates Cardiac Fibrosis and Dysfunction in Pressure-overloaded Hearts
Author(s):
Yusuke Higuchi
,
Takehiro Ogata
,
Masahiro Nishi
,
et al
Added:
3 years ago
Article